Nanoemulsions

Nanoemulsions

Global Nanoemulsions Market to Reach $18.4 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Nanoemulsions estimated at US$10.1 Billion in the year 2022, is projected to reach a revised size of US$18.4 Billion by 2030, growing at aCAGR of 7.8% over the period 2022-2030. Topical, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Oral segment is readjusted to a revised 8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 7.4% CAGR
The Nanoemulsions market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Select Competitors (Total 43 Featured) -

  • AbbVie, Inc.
  • Allergan PLC
  • AstraZeneca PLC
  • Covaris, Inc.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Kaken Pharmaceutical Co., Ltd.
  • NanoBio Corporation
  • Novartis International AG
  • Sanofi SA
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Nanoemulsions – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World 8-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 4: World 8-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 6: World 8-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 8: World 8-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 9: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 10: World 8-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 12: World 8-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: World 8-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 15: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 16: World 8-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Immunosuppressant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 18: World 8-Year Perspective for Immunosuppressant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Antiretroviral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 20: World 8-Year Perspective for Antiretroviral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 21: World Recent Past, Current & Future Analysis for Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 22: World 8-Year Perspective for Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Vasodilators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 24: World 8-Year Perspective for Vasodilators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
TABLE 25: World Nanoemulsions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 27: USA 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 28: USA Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 29: USA 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
CANADA
TABLE 30: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 31: Canada 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 33: Canada 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
JAPAN
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 34: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 35: Japan 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 36: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 37: Japan 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
CHINA
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 39: China 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 40: China Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 41: China 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
EUROPE
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 42: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 43: Europe 8-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 45: Europe 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 46: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 47: Europe 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
FRANCE
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 48: France Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 49: France 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 50: France Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: France 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
GERMANY
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
TABLE 52: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 53: Germany 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 54: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 55: Germany 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
ITALY
TABLE 56: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: Italy 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 58: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 59: Italy 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
UNITED KINGDOM
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
TABLE 60: UK Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 61: UK 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 62: UK Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: UK 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
REST OF EUROPE
TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 65: Rest of Europe 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 66: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 67: Rest of Europe 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
ASIA-PACIFIC
Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Asia-Pacific 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 70: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 71: Asia-Pacific 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
REST OF WORLD
TABLE 72: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 73: Rest of World 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
TABLE 74: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: Rest of World 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings